LUV |
Rice Bran |
scCO2
|
480.9 ± 270.8 |
47.54–64.47 |
Skin Aging |
Anti-aging effects in gel and cream |
Rabit Skin/Fibroblast cells |
Skin lightning, thickness, roughness and elasticity improvement |
[126] |
LUV |
Lycopene |
Adsorption-Hydration |
175–235 |
62.8 ± 2 |
Diabetes |
Anti-Diabetic vesicles |
Wistar rat |
Efficient delivery. |
[130] |
Blood glucose level reduction |
LUV |
Lycopene |
Adsorption-Hydration |
170–230 |
62.76 ± 2 |
Cervical and breast Cancer |
Lycopene encapsulation |
MCF-7 and HeLa cells, Wistar rat |
Anti-cancer activity |
[137] |
SUV |
Zingiber |
Film hydration |
100 |
– |
Inflammation |
|
Wistar rat |
Antioxidant and anti-inflammatory |
[131] |
LUV |
Turmeric |
Transmembrane pH gradient |
400–500 |
81.69 |
Mosquito vectors |
|
Against larvae |
Mortality of larvae |
[138] |
LUV |
Embelin |
Thin film hydration |
500–700 |
63.32–80.00 |
Diabetes |
|
Wistar rat |
Hypoglycemic activity |
[118] |
LUV |
Gymnema sylvestre |
Thin film hydration |
229.5 ± 30 |
57.8–85.3 |
Diabetes |
Anti-Diabetic vesicles |
Wistar rat |
|
[139] |
LUV |
Silymarin |
Hand Shaking |
256.2–541.1 |
43.8–70.61 |
|
Hepatoprtective |
Wistar rat |
Increasing drug bioavailability |
[140] |
LUV |
Ellagic acid |
Reverse phase evaporation |
124–1776 |
1.35–26.75 |
|
|
Human skin & Franz diffusion cell |
Efficient delivery of EA through epidermis |
[141] |
LUV |
Ammonium Glycyrrhizinate |
Thin film hydration and high-speed stirring |
363–622 |
13.2–40 |
Eczema and psoriasis |
Dermal administration |
– |
|
[142] |
LUV |
Resveratrol |
Thin film hydration |
139–227 |
16.8–72.5 |
– |
Yoghurt additive |
– |
– |
[143] |
SUV and LUV |
Nerium oleander |
Thin film hydration |
59.1–334.0 |
13.24–16.20 |
|
|
Alveolar type-II and cervical cancer cell |
Antioxidant activity |
[144] |
LUV |
Curcumin |
Thin film hydration |
250 ± 20 |
90 |
Cancer |
Anticancer, anti-tubercular and anti-inflammatory |
HeLa |
Multi-drug delivery enhancement |
[29] |
LUV |
Morusin |
Thin film hydration |
479 |
97 |
Cancer |
Anticancer therapy |
MDA-MB-453, HT-29, PANC-1, SKOV-3, and L929 |
|
[145] |
SUV |
Curcumin |
Thin film and pH-gradient |
48–185.9 |
50.21–95.11 |
Cancer |
Anticancer therapy |
Saos-2, MG-63, and KG-1 |
Multi hydrophilic and hydrophobic drug delivery |
[119] |
LUV |
Papain |
Thin film hydration and sonication |
220.7–520.2 |
– |
Scar of skin |
Skin treatment |
Sprague-Dawley rats' skin |
Skin permeation enhancement |
[146] |
LUV |
Gambogenic acid |
Ethanol injection |
98.3–299.7 |
36.09–68.20 |
Cancer |
Anticancer drug candidate |
– |
Effective release and increasing duration |
[22] |
SUV |
Curcumin |
Thin film hydration |
101.5–125.1 |
52.24–85.42 |
Cancer |
Anticancer therapy |
MCF-7, MCF-10A |
Improving therapeutic effectiveness of cancer treatments |
[121] |
LUV |
Green tea |
Thin film hydration |
338.3 |
56.39–77.80 |
Skin Protection |
Antioxidants niosomal gel |
– |
Efficient encapsulation |
[147] |
LUV |
Resveratrol |
Thin film hydration and ethanol injection |
284 ± 28–496 ± 39 |
15±1–48 ± 3 |
Skin inflammation and irritation |
Topical use and delivery |
Newborn Pig skin |
|
[125] |
SUV |
Morin |
Thin film hydration |
109–233 |
55.47–78.94 |
Cancer and Parkinson |
Antioxidant and anticancer activity in brain |
Wistar rat |
Improvement in AUC of MH |
[148] |
MLV |
Ellagic acid |
Reverse phase evaporation |
312–560 |
25.63–38.73 |
– |
Dermal delivery system |
Human skin |
Permeation enhancement to the skin |
[132] |
LUV |
Aloe vera |
Reverse phase evaporation |
270.08 |
42.04 |
Skin defects and wounds |
Skin wound dressing |
Fibroblast cell |
Accelerating healing process |
[149] |
– |
Silibinin |
Reverse phase evaporation |
– |
49.50–86.38 |
Cancer |
Anti-tumoural activity |
T47D cell |
Altering level of miRNA expression |
[150] |
– |
Resveratrol |
Thin film hydration |
– |
97.00 ± 0.02 |
– |
Hydrogel systems encapsulating niosomes |
– |
Preventing trans-to-cis photoisomerization of resveratrol |
[123] |
MLV and SUV |
Resveratrol |
Mechanical agitation and sonication |
200–900 |
<40.96 |
Antioxidant |
Functional food |
– |
|
[151] |
SUV |
Rice Bran |
chloroform film method with sonication |
44.86–75.67 |
– |
– |
Anti-hair loss products |
Fibroblast cell |
|
[127] |
LUV |
Ginkgo biloba |
Film dispersion–homogenization |
140.9–505.1 |
38.7–57.7 |
Auto-oxidation, antitumor, protective in nervous system |
Delivery of GbE to the brain |
Wistar rat |
|
[152] |
– |
Curcumin |
Ether injection |
– |
– |
– |
Transdermal formulation gel |
Wistar rat skin |
– |
[122] |
LUV |
Artemisia absinthium |
Thin film hydration |
174 ± 2.56 |
66.73 |
Amyloid aggregation |
|
– |
|
[153] |
SUV |
Marigold |
Thin film hydration |
57.61 ± 25.27 and 82.72 ± 21.92 |
59 |
Cytotoxicity, wound healing, antioxidant |
|
Vero cell |
|
[154] |
LUV |
Zingiber |
|
690 and 1930 |
– |
|
Anti-inflammatory |
Newborn pigs skin and Male ICR mice |
Chemical stability and skin permeation enhancement |
[155] |
LUV |
Propolis |
Reverse phase evaporation |
237–333 |
91 ± 0.48 |
Oral recurrent aphthous ulcer |
Antimicrobial compound |
Franz diffusion cell |
|
[156] |
SUV |
Carum |
Thin film hydration |
100–200 |
86.25–92.32 |
Cancer |
Breast cancer treatment |
MCF7 |
Novel high efficiency carrier |
[157] |